Azeria Therapeutics has wound down voluntarily four years after being set up to advance University of Cambridge and Cancer Research UK work.

Stanford-StartX Fund-backed Nearpod has agreed to an acquisition by Renaissance Holding.

Proeza-backed electric truck producer Xos will list on the Nasdaq Stock Market and have an implied pro forma market capitalisation of $2bn.

Centessa has been formed as a biotech conglomerate with $250m in funding following a ten-way merger, including multiple spinouts.

Main Sequence Ventures-backed FluroSat has joined forces with its peer Dagan and the combined business will operate from the US as Regrow.

Commerzbank, Visa and CreditEase could be in line for exits after the card issuing platform developer confidentially filed to go public at a possible $10bn valuation.

Baidu Ventures, Mango Media and Zhongnan Red Cultural Group are set to exit the screen projector producer in an IPO on Shanghai’s Star Market.

The New York Times, Automattic, WGBH, American Public Media, McClatchy, Graham Holdings and Bose have exited the podcasting platform developer through the deal.

MedPilot, a developer of healthcare revenue management software, has been acquired after raising $3.6m from backers including Cedars-Sinai Accelerator.

Fresenius Medical Care and Access Industries-backed Humacyte will merge with Alpha Healthcare Acquisition Corp to become a public business with a market cap of $1.1bn.